Demon Stock Metamorphosis： Play More Receives Concern Letter Shenzhen Stock Exchange Names Committed to Downfall

“Demon Stock” Metamorphosis: “Play More” Receives Concern Letter Shenzhen Stock Exchange Names Committed to Downfall
After the A-share index closed up the whole day before, on March 11, the two cities closed down again, and 2621 stocks fell.Under the haze of the new crown pneumonia epidemic and the “crude oil price war”, the global stock market was frustrated, and the Shanghai Stock Index also entered a period of shock in nearly 10 trading days.In fact, the remaining stocks went against the market and continued to grow.Sauna, Yewang combed and found that until the closing on March 11, except for new stocks such as Liangpin Shop, BOC Securities, Baobian Electric, Hite Bio, Guoen Shares, and Haiyuan Fucai have increased by more than 100% in the past 10 trading days., Which can be doubled continuously.These companies even “collectively” warned of the risks, but the rally has stopped.However, there are exceptions.The Shenzhen Stock Exchange disclosed on March 6 that it continued to carry out key monitoring of the “Saturday”, which has experienced an abnormal increase for many consecutive days.On that day, after the thrilling drama on “Saturday”, it may have fallen for three consecutive days.4 The company started the “explosion mode”, up to 10 trading days of continuous daily limit and stop interest rate. On March 11, according to Oriental Fortune Choice data, Baobian Electric has grown for 11 consecutive trading days, gradually expanding by 165.57%, while Hite Bio, Guoen Co., Ltd. and Haiyuan Composite Materials have also risen for 10 consecutive trading days, 9 trading days and 8 trading days respectively, with a gradual growth rate of 140 each.03%, 135.86% and 110.61%.The main transformer and transformer Baobao Electric’s 11 consecutive trading days of growth began on February 26, of which nearly 10 trading days of continuous daily limit, has been from 3.05 yuan / share increased to 8 closed on March 11.10 yuan / share, a gradual increase of 165.57%.The reporter noticed that as early as February 7 this year, the listed company Baoding Tianwei Baobian Electric Co., Ltd. (stock abbreviation: Baobian Electric 600550) held a board meeting and passed relevant indicators on the company ‘s non-public offering of stocks, and thenOn February 25, 2020, a revised version of the plan for the non-public offering of A shares was disclosed.At present, China Weaponry Equipment Group Co., Ltd., which has obtained the controlling shareholder’s shareholding rights from Baobian Electric for its non-public stock issue, has raised a total of no more than US $ 500 million. The final subscription price will be determined after the approval of the CSRC is issued.Guoen and Hite Biotech were sought after in the secondary market for “mask materials” and “new medicines” respectively.On February 27 this year, the listed company Qingdao Guoen Technology Co., Ltd. (stock abbreviation: Guoen Shares 002768) disclosed that the “2019 Annual Results Express” showed that the company has been working in the field of polymer modification for more than 20 years, facing the melt blown masks.Due to the shortage of polypropylene in the epidemic situation, the company set up a project team as soon as possible after the resumption of work, and carried out equipment transformation based on the reorganized formula. According to different product grades (including N95 masks) and customer requirements, masterbatch addition and blending were used.Two processes were launched to quickly complete the large-scale production of melt-blown polypropylene for masks.Affected by the above-mentioned news, since February 28, Guoen shares have been in a daily limit of 9 consecutive days, from 23.RMB 70 / share rose to the closing price of 55 on March 11.90 yuan / share, a gradual increase of 135.86%.Before and after, the listed company Wuhan Haite Bio-Pharmaceutical Co., Ltd. (stock abbreviation: Haite Bio 300683) disclosed on February 26 that its phase III clinical trial of a new anti-cancer drug was blinded, and the results reached expectations.From the next day, Hite Bio has been able to grow continuously for 10 consecutive trading days, and the daily limit for nearly 9 consecutive trading days has been increased from 31.98 yuan / share rose to 76 closed on March 11.76 yuan / share, an increase of 140.03%.Haiyuan Fucai’s “play more” received the letter, and the risk warning did not affect the proportion of the rally, while Haiyuan’s “play code” caused a little more.Starting from the disclosure of the transfer of control rights on January 16 of this year and the disclosure of the closing of the pledged shares of shareholders on January 19, the listed company Fujian Haiyuan Composite Material Technology Co., Ltd. (stock abbreviation: Haiyuan Fucai 002529) has staged “transfer control”Rights-the controlling shareholder pledged to be liquidated-termination of the transfer of control rights-re-transfer of control rights “scenario, continuous growth for nearly 8 trading days, gradually expanding by 110.61%.The difference is that Haiyuan Fucai has received the letter of concern issued by the Shenzhen Stock Exchange on March 2.In fact, after the sustainable start of the “inflation mode”, the above companies have already warned of risks.However, as of the close of trading on March 11, the four companies have continued to grow, and all of them still closed at the daily limit.On March 9th, Baobian Electric warned of risk measurement. The company expects to achieve a net profit of approximately 15 million attributable to shareholders of listed companies in 2019. Compared with the same period of last year, it will achieve a turnaround, but it may be 49.8 million yuan after deduction.Around 2019, it is estimated that in 2018, the net profit of the non-returning mother will be negative, and the profitability of the main business will be weak.Absolute value, Baobian Electric said that the company’s annual asset-liability ratio is high, and the asset-liability ratio at the end of the third quarter of 2018 and 2019 was 86.62% and 86.52%.As of the end of the third quarter of 2019, the company has not cashed the balance of monetary funds5.3 billion, short-term borrowing 25.3.5 billion US dollars, there is a funding gap.In addition, on March 10th, Guoen announced the exception of stock trading exceptions. The company already has 15 production lines for meltblown polypropylene special materials, and it also prompts risk weighing. The company’s masks use meltblown polypropylene products inStarted production in mid-February this year, and finally the company has achieved a daily output of 150 tons, which accounts for a small amount of the overall business segment of the company; meltblown polypropylene for masks is only one of the company ‘s products, and other parts of the company ‘s products are currently to a certain extent.Be adversely affected by the epidemic.As early as a day or two before some companies, Hite Bio advised on March 8 that the results of its new anti-cancer drugs will not have a significant impact on the company ‘s recent performance, but only the preliminary analysis of key data, which is complete, effective and safe.Sexual results will be subject to the final analysis results of the statistical analysis report.New drug R & D is affected by many factors such as technology, approval, and policies. There are many uncertain risks related to the progress of R & D and future product market competition trends.Deformation of “demon stock”: Focused on Saturday monitoring, the reporter sitting in front of the roller coaster noticed that the exchange has recently supervised some of the serious increase in stocks.This year, there are not a few stocks that have experienced serious growth in the short term. “Saturday (002291)” and “Sou Yute (002503)” are among the “outstanding leaders.”However, on March 6, the Shenzhen Stock Exchange revealed that it continued to conduct key monitoring on the “Saturday” and “Souyute”, which have experienced abnormal increases for many consecutive days, and took timely regulatory measures.Since December 13, 2019, it has risen from less than 7 yuan all the way around Saturday and climbed to 36 at the highest.56 yuan / share.This can be said to be a hot Internet celebrity economic concept leader has twice staged the thrilling drama of late-stage explosives.Among them, as of January 17th, the first late-breaker board, on Saturday, achieved 16 daily limit within 24 trading days.This is generally believed to have benefited from the online celebrity e-commerce Li Ziqi on Saturday, but as early as last year, on Saturday, investors had responded to investors on the online platform, “Li Ziqi is not the company’s contracted celebrity.”On Saturday, March 6, I received a letter of concern from the Shenzhen Stock Exchange, asking the company to indicate whether there are other non-information disclosure channels to actively cater to “new retail”, “webcast” and other market hotspots, conduct company frying hype and cooperate with shareholders to reduceHold the facts.On the evening of March 11th, he responded to the letter of concern on Saturday, denying that the hot spot hype was achieved.Regarding the “whether or not your company’s operating conditions and internal and external operating environment are or are expected to undergo major changes” proposed by the Shenzhen Stock Exchange, there was no positive answer on Saturday, but it re-raised again that this outbreak is expected to occur within a certain period of time.The offline sales business has a competitive impact.However, as of the close of the day, Saturday may decrease by 4.82%, reported 25.86 yuan / share, gradually reduced by 22 in the last 4 trading days.04%.The other “monster stock” that is being monitored is produced from epidemic materials such as cross-border masks such as youth casual clothing of the “trend front” brand.On February 12, the collected announcement announced that the company will invest in the establishment of a wholly-owned subsidiary, Dongguan City, to collect medical supplies Co., Ltd., the business scope (to be planned) includes medical sanitary masks, protective clothing, gauze, non-woven fabrics, etc.Then in 10 trading days from February 25 to March 9, Sohuite once walked out of 8 rising stops, during which the maximum expansion reached 129%.On March 4, the Shenzhen Stock Exchange issued a concern letter asking the company to indicate whether it has produced and sold medical sanitary masks, protective clothing and other medical devices and related product qualifications.On March 10, Soyute responded that on February 29, the medical supplies company received the relevant filing submitted by the Dongguan Municipal Market Supervision Administration; “medical disposable protective clothing” needs to supplement the test report of skin irritation and other indicators, it is expectedThe product record and production record can be obtained in mid-March.After experiencing a wave of rapid rises, Soyut fell 10 for two consecutive trading days on March 10 and 11.05% and 8.98%, a gradual decline of 18.13%, conservatively closed 4.56 yuan / share.Sauna, Ye Wang Xiao Wei Zhang Zeyan editor Wang Jinyu proofreading Jia Ning reporter contact email: xiaowei @ xjbnews.comzhangzeyan @ xjbnews.com